[ad_1]
The news about new strain of coronavirus which has been found primarily in Britain has caused quite a stir around the world as the pandemic continues to spread throughout the world. One of the reasonable questions that have arisen is whether the vaccines that have already been prepared will be as effective against this mutation.
Its president and CEO Pfizer, Albert MockeryIn the exclusive interview he gave to the main ERT1 newsletter on Thursday night, he was asked to respond on this topic. Although he said “moderately optimistic“That the vaccines will prove to be equally effective in this strain, however he was quick to add that”we don’t know for sure at this point». He even said that in about two weeks there will be enough evidence to confirm or not the effectiveness of the vaccine against the new strain.
In case the vaccine needs something “settingsTo deal with the mutation effectively, he said, “it can be done ‘relatively quickly.’
Speaking about the number of vaccines that will be available in the European Union, he said that in 2021 they will be given 200 million installments. He noted that the EU has the right to request An additional 100 million doses of vaccines, “which we will do everything possible to give them,” he said.
He also stated that each country will receive its share, in proportion to the population, noting that the Hellas you will receive approximately 2 million doses. He estimated that our country will receive between 90-100 thousand quotas in December. He also assured that the doses of the vaccine will be delivered and delivered on time at the vaccination points and in accordance with the corresponding safety standards.
Finally, referring to how long the pandemic will last, he significantly highlighted that “at this moment the solutions we have in our hands are so effective that they are matter of time to get to the end “.
